357 related articles for article (PubMed ID: 12117305)
21. Inhibitory, facilitatory, and excitatory effects of ATP and purinergic receptor agonists on the activity of rat cutaneous nociceptors in vitro.
Yajima H; Sato J; Giron R; Nakamura R; Mizumura K
Neurosci Res; 2005 Apr; 51(4):405-16. PubMed ID: 15740803
[TBL] [Abstract][Full Text] [Related]
22. Cardiomyogenesis of embryonic stem cells upon purinergic receptor activation by ADP and ATP.
Mazrouei S; Sharifpanah F; Bekhite MM; Figulla HR; Sauer H; Wartenberg M
Purinergic Signal; 2015 Dec; 11(4):491-506. PubMed ID: 26395809
[TBL] [Abstract][Full Text] [Related]
23. Secretion of ATP from Schwann cells in response to uridine triphosphate.
Liu GJ; Werry EL; Bennett MR
Eur J Neurosci; 2005 Jan; 21(1):151-60. PubMed ID: 15654852
[TBL] [Abstract][Full Text] [Related]
24. ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors in mice.
Amisten S; Meidute-Abaraviciene S; Tan C; Olde B; Lundquist I; Salehi A; Erlinge D
Diabetologia; 2010 Sep; 53(9):1927-34. PubMed ID: 20526761
[TBL] [Abstract][Full Text] [Related]
25. Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles.
Horiuchi T; Dietrich HH; Hongo K; Dacey RG
Stroke; 2003 Jun; 34(6):1473-8. PubMed ID: 12730558
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory action of PPADS on relaxant responses to adenine nucleotides or electrical field stimulation in guinea-pig taenia coli and rat duodenum.
Windscheif U; Pfaff O; Ziganshin AU; Hoyle CH; Bäumert HG; Mutschler E; Burnstock G; Lambrecht G
Br J Pharmacol; 1995 Aug; 115(8):1509-17. PubMed ID: 8564212
[TBL] [Abstract][Full Text] [Related]
27. Functional evidence that ATP or a related purine is an inhibitory NANC neurotransmitter in the mouse jejunum: study on the identity of P2X and P2Y purinoceptors involved.
De Man JG; De Winter BY; Seerden TC; De Schepper HU; Herman AG; Pelckmans PA
Br J Pharmacol; 2003 Nov; 140(6):1108-16. PubMed ID: 14530212
[TBL] [Abstract][Full Text] [Related]
28. P2Y purinergic potentiation of glucose-induced insulin secretion and pancreatic beta-cell metabolism.
Farret A; Vignaud M; Dietz S; Vignon J; Petit P; Gross R
Diabetes; 2004 Dec; 53 Suppl 3():S63-6. PubMed ID: 15561924
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory purinergic P2 receptor characterisation in rat distal colon.
Van Crombruggen K; Van Nassauw L; Timmermans JP; Lefebvre RA
Neuropharmacology; 2007 Aug; 53(2):257-71. PubMed ID: 17612577
[TBL] [Abstract][Full Text] [Related]
30. Stable adenine nucleotides inhibit [3H]-noradrenaline release in rabbit brain cortex slices by direct action at presynaptic adenosine A1-receptors.
von Kügelgen I; Späth L; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):187-96. PubMed ID: 1448182
[TBL] [Abstract][Full Text] [Related]
31. Purinoceptor modulation of noradrenaline release in rat tail artery: tonic modulation mediated by inhibitory P2Y- and facilitatory A2A-purinoceptors.
Gonçalves J; Queiroz G
Br J Pharmacol; 1996 Jan; 117(1):156-60. PubMed ID: 8825357
[TBL] [Abstract][Full Text] [Related]
32. HEK293 human embryonic kidney cells endogenously express the P2Y1 and P2Y2 receptors.
Schachter JB; Sromek SM; Nicholas RA; Harden TK
Neuropharmacology; 1997 Sep; 36(9):1181-7. PubMed ID: 9364473
[TBL] [Abstract][Full Text] [Related]
33. Purinergic receptor signaling at the basolateral membrane of macula densa cells.
Liu R; Bell PD; Peti-Peterdi J; Kovacs G; Johansson A; Persson AE
J Am Soc Nephrol; 2002 May; 13(5):1145-51. PubMed ID: 11961001
[TBL] [Abstract][Full Text] [Related]
34. Vasoconstrictor and vasodilator responses to various agonists in the rat perfused mesenteric arterial bed: selective inhibition by PPADS of contractions mediated via P2x-purinoceptors.
Windscheif U; Ralevic V; Bäumert HG; Mutschler E; Lambrecht G; Burnstock G
Br J Pharmacol; 1994 Nov; 113(3):1015-21. PubMed ID: 7858843
[TBL] [Abstract][Full Text] [Related]
35. Cross talk between P2 purinergic receptors modulates extracellular ATP-mediated interleukin-10 production in rat microglial cells.
Seo DR; Kim SY; Kim KY; Lee HG; Moon JH; Lee JS; Lee SH; Kim SU; Lee YB
Exp Mol Med; 2008 Feb; 40(1):19-26. PubMed ID: 18305394
[TBL] [Abstract][Full Text] [Related]
36. Purinergic modulation of the evoked release of [3H]acetylcholine from the hippocampus and cerebral cortex of the rat: role of the ectonucleotidases.
Cunha RA; Ribeiro JA; Sebastião AM
Eur J Neurosci; 1994 Jan; 6(1):33-42. PubMed ID: 8130931
[TBL] [Abstract][Full Text] [Related]
37. ATP inhibits Ins(1,4,5)P3-evoked Ca2+ release in smooth muscle via P2Y1 receptors.
MacMillan D; Kennedy C; McCarron JG
J Cell Sci; 2012 Nov; 125(Pt 21):5151-8. PubMed ID: 22899721
[TBL] [Abstract][Full Text] [Related]
38. Different receptors mediating the inhibitory action of exogenous ATP and endogenously released purines on guinea-pig intestinal peristalsis.
Heinemann A; Shahbazian A; Barthó L; Holzer P
Br J Pharmacol; 1999 Sep; 128(2):313-20. PubMed ID: 10510440
[TBL] [Abstract][Full Text] [Related]
39. Regulation of brain capillary endothelial cells by P2Y receptors coupled to Ca2+, phospholipase C and mitogen-activated protein kinase.
Albert JL; Boyle JP; Roberts JA; Challiss RA; Gubby SE; Boarder MR
Br J Pharmacol; 1997 Nov; 122(5):935-41. PubMed ID: 9384512
[TBL] [Abstract][Full Text] [Related]
40. Diadenosine polyphosphates in insulin-secreting cells: interaction with specific receptors and degradation.
Verspohl EJ; Johannwille B
Diabetes; 1998 Nov; 47(11):1727-34. PubMed ID: 9792542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
